Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiraku Endo

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cytokine|September 9, 2017
Interleukin 34, from pathogenesis to clinical applicationsMuhammad Baghdadi, Hiraku Endo, Yoshino Tanaka, et al.
Inflammation and Regeneration|March 9, 2018
Enhanced IL-34 expression in Nivolumab-resistant metastatic melanomaNanumi Han, Muhammad Baghdadi, Kozo Ishikawa, et al.
Inflammation and Regeneration|July 14, 2018
Enhanced expression of IL-34 in an inflammatory cyst of the submandibular gland: a case reportMuhammad Baghdadi, Kozo Ishikawa, Hiraku Endo, et al.
International Journal of Clinical Oncology|November 15, 2021
Current state of fertility preservation for adolescent and young adult patients with gynecological cancerTatsuru Ohara, Shiho Kuji, Tomo Takenaga, et al.
Scientific Reports|January 12, 2018
High co-expression of IL-34 and M-CSF correlates with tumor progression and poor survival in lung cancersMuhammad Baghdadi, Hiraku Endo, Atsushi Takano, et al.
International Cancer Conference Journal|July 5, 2021
Primary malignant melanoma of uterine cervix treated with pembrolizumab as adjuvant immunotherapyReiko Suzuki, Hiraku Endo, Takamichi Sasaki, et al.
International Immunology|December 24, 2019
Interleukin-34 expression in ovarian cancer: a possible correlation with disease progressionHiraku Endo, Naoki Hama, Muhammad Baghdadi, et al.
Blood Advances|February 21, 2019
A role for IL-34 in osteolytic disease of multiple myelomaMuhammad Baghdadi, Kozo Ishikawa, Sayaka Nakanishi, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cytokine|September 9, 2017
Interleukin 34, from pathogenesis to clinical applicationsMuhammad Baghdadi, Hiraku Endo, Yoshino Tanaka, et al.
Inflammation and Regeneration|March 9, 2018
Enhanced IL-34 expression in Nivolumab-resistant metastatic melanomaNanumi Han, Muhammad Baghdadi, Kozo Ishikawa, et al.
Inflammation and Regeneration|July 14, 2018
Enhanced expression of IL-34 in an inflammatory cyst of the submandibular gland: a case reportMuhammad Baghdadi, Kozo Ishikawa, Hiraku Endo, et al.
International Journal of Clinical Oncology|November 15, 2021
Current state of fertility preservation for adolescent and young adult patients with gynecological cancerTatsuru Ohara, Shiho Kuji, Tomo Takenaga, et al.
Scientific Reports|January 12, 2018
High co-expression of IL-34 and M-CSF correlates with tumor progression and poor survival in lung cancersMuhammad Baghdadi, Hiraku Endo, Atsushi Takano, et al.
International Cancer Conference Journal|July 5, 2021
Primary malignant melanoma of uterine cervix treated with pembrolizumab as adjuvant immunotherapyReiko Suzuki, Hiraku Endo, Takamichi Sasaki, et al.
International Immunology|December 24, 2019
Interleukin-34 expression in ovarian cancer: a possible correlation with disease progressionHiraku Endo, Naoki Hama, Muhammad Baghdadi, et al.
Blood Advances|February 21, 2019
A role for IL-34 in osteolytic disease of multiple myelomaMuhammad Baghdadi, Kozo Ishikawa, Sayaka Nakanishi, et al.
Pageof 1